SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREG FINLEY who wrote (303)8/26/1998 2:31:00 PM
From: Marc Kahn   of 534
 
It's a common saying that no one rings a bell at the bottom. I disagree.

Ring ring ring...

I'm noticing something very encouraging here. On August 13, 21, and again today, the 26th, Bioject's shares traded at about $1.20. On each of those days, the price snapped back immediately, on very good volume. I believe that we are establishing a strong support level here, at about 1 1/4. At this level, there is not enough profit in it for those holders of converted warrants who have been our source of supply on the way down. Those of us who know the value of our company are providing demand.

I increased my position on 8/21 at 1 7/32 and 1 1/4. Bought some more today at 1 1/4.

May I suggest that for those of you so inclined, GTC limit orders to buy at 1 1/4 will accomplish 2 noble goals:

1. Further establish this support level for the price of our stock
2. Increase your positions at a truly bargain price.

Ring ring ring...

Marc Kahn
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext